Scott Tetreault, MD

Scott  Tetreault, MD


Languages Spoken

  • English

Start a telemedicine call with

Dr. Tetreault

Enter waiting room
(for scheduled appointments only)

Please call the office to schedule your telehealth visit today.

Telemedicine by
Page Divider

Dr. Tetreault is triple Board-certified in medical oncology, hematology, internal medicine and palliative medicine. He was awarded the Rhone Poulenc Fellowship Award in 1998 for Breast Cancer Research. Other honors include selection by his peers in 2003 as Doctor of the Year, Goldman Award for contributions to the Cancer Community in 2009 and selection by the Consumer Research Council as one of “America’s Top Oncologists” every year since 2006.

Widely published in the scientific literature, Dr. Tetreault is an investigator in over 50 clinical trials. Dr Tetreault was the principal investigator for the DYNAMO trial which led to the FDA approval of Duvelisib (Copiktra) as a novel agent for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma. He is a member of the American Society of Clinical Oncology, The American College of Physicians and was recently granted honor of being selected as a Fellow of the Royal Society of Medicine in the U.K.

Dr. Scott Tetreault, Medical Oncologist, explains how the field of oncology has changed since he began practicing 25 years ago

Ted Helms Testimonial - Dr. Scott Tetreault Patient - Florida Cancer Specialists


Undergraduate School

Wake Forest University

Medical School

University of Miami Miller School of Medicine

Internship and Residency

University of Florida Shand’s Hospital

Fellowship in Oncology

Scripps Clinic and Research Foundation - La Jolla, CA

Board Certified

Medical Oncology


Internal Medicine

Board Appointments

Executive Committee Member, Florida Society of Clinical Oncology (FLASCO)

Executive Committee, Community Oncology Alliance (COA)

Professional Memberships & Associations

Florida Association of Clinical Oncology (FLASCO) - Legislative Committee Member